We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$92.8M
Cap. Flow
+$15.3M
Cap. Flow %
1.3%
Top 10 Hldgs %
4.44%
Holding
1,192
New
267
Increased
346
Reduced
321
Closed
257

Top Buys

Rank Stock Value
1
LRN icon
Stride
LRN
+$5.17M
2
FDX icon
FedEx
FDX
+$4.67M
3
QSR icon
Restaurant Brands International
QSR
+$4.66M
4
LKQ icon
LKQ Corp
LKQ
+$4.61M
5
AAL icon
American Airlines Group
AAL
+$4.59M

Sector Composition

Rank Sector Weight
1 Technology 18.31%
2 Industrials 15.94%
3 Consumer Discretionary 15.09%
4 Healthcare 11.66%
5 Financials 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADNT icon
826
Adient
ADNT
$1.65B
$258K 0.02%
+13,276
New +$196K
COO icon
827
Cooper Companies
COO
$14.1B
$258K 0.02%
3,626
-24,633
-87% -$1.89M
KD icon
828
Kyndryl
KD
$2.99B
$256K 0.02%
+6,108
New +$221K
HAPN
829
Happen Inc
HAPN
$2.21B
$255K 0.02%
21,226
-12,129
-36% -$126K
IIIN icon
830
Insteel Industries
IIIN
$593M
$255K 0.02%
+6,856
New +$229K
SNDX icon
831
Syndax Pharmaceuticals
SNDX
$1.69B
$255K 0.02%
27,231
-45,327
-62% -$499K
ITGR icon
832
Integer Holdings
ITGR
$4.12B
$252K 0.02%
2,047
-738
-26% -$88.1K
TRP icon
833
TC Energy
TRP
$70.2B
$251K 0.02%
+5,138
New +$252K
BHC icon
834
Bausch Health
BHC
$2.58B
$249K 0.02%
37,424
+13,623
+57% +$70K
XEL icon
835
Xcel Energy
XEL
$48.8B
$248K 0.02%
+3,648
New +$253K
RCKT icon
836
Rocket Pharmaceuticals
RCKT
$340M
$247K 0.02%
+100,780
New +$511K
CGNT icon
837
Cognyte Software
CGNT
$659M
$247K 0.02%
+26,720
New +$263K
KODK icon
838
Kodak
KODK
$822M
$245K 0.02%
43,347
+6,073
+16% +$36.5K
PRSU
839
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
$245K 0.02%
8,481
-15,495
-65% -$457K
FTRE icon
840
Fortrea Holdings
FTRE
$1.82B
$242K 0.02%
49,073
+34,908
+246% +$188K
DRH icon
841
Diamondrock Hospitality Co
DRH
$2.71B
$240K 0.02%
+31,368
New +$234K
CGEM icon
842
Cullinan Oncology
CGEM
$1.01B
$240K 0.02%
31,853
-11,554
-27% -$92.8K
ARLO icon
843
Arlo Technologies
ARLO
$1.6B
$237K 0.02%
14,002
+1,472
+12% +$18.8K
MWA icon
844
Mueller Water Products
MWA
$3.95B
$237K 0.02%
+9,871
New +$244K
AGNT
845
AGNT Inc
AGNT
$666M
$237K 0.02%
26,069
-218
-0.8% -$1.9K
ULCC icon
846
Frontier Group Holdings
ULCC
$1.55B
$236K 0.02%
65,061
-7,066
-10% -$25.9K
FNV icon
847
Franco-Nevada
FNV
$41.1B
$236K 0.02%
+1,439
New +$238K
CDE icon
848
Coeur Mining
CDE
$15.4B
$236K 0.02%
+26,614
New +$194K
REG icon
849
Regency Centers
REG
$14.7B
$235K 0.02%
3,296
-2,627
-44% -$188K
AI icon
850
C3.ai
AI
$1.43B
$234K 0.02%
+9,512
New +$217K

Similar funds

Nebula Research & Development's Q2 2025 Portfolio in Review

As of Q2 2025, Nebula Research & Development held 1,192 positions worth $1.17B, up 8.6% from $1.08B the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

Nebula Research & Development's Q2 2025 filing shows 267 new, 346 increased, 321 reduced and 257 closed positions. Its largest new stake was Stride: 35,744 shares worth $5.19M. The largest sale was United Parcel Service, an estimated $4.82M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Nebula Research & Development's largest Q2 2025 buy was Stride: 35,744 shares worth $5.19M.
  • Nebula Research & Development added most to A.O. Smith in Q2 2025, an estimated $4.11M increase.
  • Nebula Research & Development's biggest Q2 2025 reduction was Agilent Technologies, cutting an estimated $4.12M.
  • Nebula Research & Development fully exited United Parcel Service in Q2 2025, selling an estimated $4.82M.
  • Nebula Research & Development's ten largest holdings make up 4.4% of its $1.17B portfolio in Q2 2025.
  • Nebula Research & Development opened 267 new positions and closed 257 in Q2 2025.
  • Nebula Research & Development's portfolio value rose 8.6% quarter-over-quarter to $1.17B.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.